Page last updated: 2024-08-24

aptiganel and quinoxalines

aptiganel has been researched along with quinoxalines in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawasaki-Yatsugi, S; Shimizu-Sasamata, M; Yamaguchi, T; Yatsugi, S	1
Besozzi, C; Bonali, P; Borsini, F; Brambilla, A; Fodritto, F; Grippa, N; Pitsikas, N; Scandroglio, A	1
Sareen, D	1

Reviews

1 review(s) available for aptiganel and quinoxalines

Article	Year
Neuroprotective agents in acute ischemic stroke. The Journal of the Association of Physicians of India, 2002, Volume: 50 Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles	2002

Article

Year

Neuroprotective agents in acute ischemic stroke.

The Journal of the Association of Physicians of India, 2002, Volume: 50

Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles

2002

Other Studies

2 other study(ies) available for aptiganel and quinoxalines

Article	Year
Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats. The Journal of pharmacy and pharmacology, 1998, Volume: 50, Issue:8 Topics: Animals; Brain Ischemia; Cerebral Arteries; Dose-Response Relationship, Drug; Guanidines; Injections, Intravenous; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors	1998
Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia. Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:3 Topics: Animals; Behavior, Animal; Brain; Cerebral Infarction; Excitatory Amino Acid Antagonists; Forelimb; Guanidines; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neuroprotective Agents; Physical Stimulation; Proprioception; Psychomotor Performance; Quinoxalines; Rats; Rats, Inbred F344; Vibrissae	2001

Article

Year

Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.

The Journal of pharmacy and pharmacology, 1998, Volume: 50, Issue:8

Topics: Animals; Brain Ischemia; Cerebral Arteries; Dose-Response Relationship, Drug; Guanidines; Injections, Intravenous; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors

1998

Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia.

Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:3

Topics: Animals; Behavior, Animal; Brain; Cerebral Infarction; Excitatory Amino Acid Antagonists; Forelimb; Guanidines; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neuroprotective Agents; Physical Stimulation; Proprioception; Psychomotor Performance; Quinoxalines; Rats; Rats, Inbred F344; Vibrissae

2001